Allspring Global Investments Holdings, LLC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 176 filers reported holding HERON THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.

Quarter-by-quarter ownership
Allspring Global Investments Holdings, LLC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$42,265
-38.2%
41,034
-30.4%
0.00%
Q2 2023$68,364
+42.8%
58,935
+85.8%
0.00%
Q1 2023$47,885
-1.5%
31,712
+63.1%
0.00%
Q4 2022$48,610
+143.0%
19,444
+301.5%
0.00%
Q3 2022$20,000
+53.8%
4,8430.0%0.00%
Q2 2022$13,000
-96.9%
4,843
-93.5%
0.00%
-100.0%
Q1 2022$426,000
-11.8%
74,516
+40.7%
0.00%0.0%
Q4 2021$483,00052,9770.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
TANG KEVIN C 760$1,900100.00%
Velan Capital Investment Management LP 2,500,000$6,250,0005.52%
GREAT POINT PARTNERS LLC 6,360,161$15,900,4033.12%
Cheyne Capital Management (UK) LLP 318,008$795,0201.39%
TANG CAPITAL MANAGEMENT LLC 3,755,934$9,389,8351.36%
Rubric Capital Management LP 11,750,000$29,375,0001.28%
Orchard Capital Management, LLC 1,391,080$3,477,7001.17%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 267,028$667,5700.81%
CM Management, LLC 250,000$6250.75%
Tejara Capital Ltd 493,619$1,234,0480.71%
View complete list of HERON THERAPEUTICS INC shareholders